News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

Biotech/Pharma - Finance
Cambridge Startup Quartet Medicine Bags $23.25 Million Series A Financing 10/7/2015
TVA Medical Closes $15 Million Series C Financing 10/6/2015
OptiNose AS Snags $30 Million 10/6/2015
Sarepta (SRPT) Announces Pricing Of $127 Million Public Offering Of Common Stock 10/6/2015
Samuel I. Newhouse Foundation Awards Major Research Gift For FTD Biomarkers Initiative 10/6/2015
Elusys Therapeutics, Inc. Awarded Additional $16 Million Under Existing U.S. Government Contract To Complete Development Of Lyophilized Form Of Anthim (Obiltoxaximab) For Treatment Of Inhalational Anthrax 10/6/2015
Peter Thiel’s Breakout Labs Selects Four New Companies Pushing The Boundaries Of Science And Technology 10/6/2015
Sarepta (SRPT) Announces Proposed Public Offering Of Common Stock 10/6/2015
Maranon Capital Agents Senior Secured Term Loan to Refinance Biotronic NeuroNetwork 10/6/2015
Precision Biopsy Nabs $33.6 Million to Accelerate Expansion of its ClariCore Biopsy System 10/5/2015
ErgoMed Increases Its Co-Development Contribution Up To $12,000,000 In CEL-SCI (CVM)’s Phase III Head And Neck Cancer Trial 10/5/2015
Galapagos (GLPG.BR) Raises €1.2 Million Through Warrant Exercises 10/5/2015
Tauriga Sciences Inc. (TAUG) Secures $180,000 USD In Non-Convertible Debt Financing From Singapore-Based Institutional Investor 10/5/2015
Exonate Closes Second Successful Funding Round 10/5/2015
Third Rock Ventures Leads Formation of Neon Therapeutics with $55 Million Series A Round 10/2/2015
Immune Pharmaceuticals, Inc. Receives Second Tranche Of $3 Million From Discover Growth Fund 10/2/2015
anodyne microneedle Crowdfunds To Finance Human Clinical Trials 10/2/2015
Cellectar Biosciences  (NVLT) Closes On $3.3 Million Financing 10/2/2015
Nordion International (NDZ) Welcomes Milestone Funding From National Nuclear Security Administration To Advance New Source Of Medical Isotopes 10/2/2015
BioTime (BTX) Agrees To Sell $5.1 Million Of Equity 10/2/2015
BioTime (BTX) Announces The Closing Of A $20 Million Direct Registered Offering; Demand Exceeds NIS 80 Million Offered 10/2/2015
SoCal's Elcelyx Therapeutics Reels in $40 Million 10/1/2015
10 Boston Area Pharma Companies That Showed Dramatic Stock Declines 10/1/2015
Pharmalink AB Raises SEK100m To Advance Nefecon Development As New Treatment For Kidney Disease 10/1/2015
The Breast Cancer Research Foundation Commits $48.5 Million To Fund Cancer Research Worldwide 10/1/2015
Lightlake Therapeutics Inc. (LLTP) Receives Second Funding Commitment From A Prominent International Research And Development Foundation 10/1/2015
Amarantus BioSciences, Inc. Closes $5.5 Million Capital Infusion Through The Issuance Of A Combination Of Preferred Stock And Secured Debt Convertible 10/1/2015
Genisphere Closes $4 Million For Expansion Of 3DNA Targeted Drug Delivery Platform 10/1/2015
Evonexus Company PhageTech, Inc. Closes $2.4 Million Series A Financing For Commercialization Of One- Minute Blood And Urine Test 10/1/2015
NetScientific plcRelease: Proposed Placing To Raise Approximately £18.0 Million Additional Fundraising To Raise Up To Approximately £2.0 Million 10/1/2015
CDC Awards $22,800,000 To Increase Colorectal Cancer Screening 10/1/2015
The Kavli Foundation And University Partners Commit $100 Million To Brain Research 10/1/2015
Australian Biopharmaceutical Company, Paranta Biosciences, Raises AUD$7 Million And Starts First Human Clinical Trial Of Promising New Therapeutic For Cystic Fibrosis 10/1/2015
AMO Pharma Snags $25 Million 9/30/2015
Accelerator Completes $62.8 Million Financing Round to Fund Biotech Startups 9/30/2015
Therachon Bags $35 Million Financing 9/30/2015
Tunitas Therapeutics Closes $10 Million Series A Financing 9/30/2015
InnFocus Bags $32.8 Million 9/30/2015
Encycle Therapeutics Raises $2.85 Million To Advance Macrocycle Platform And Pipeline 9/30/2015
DeuteRx Announces $2.8 Million Of Seed Financing To Support Advancement Of DRX-065 For The Treatment Of Adrenoleukodystrophy (ALD) 9/30/2015
Mast Therapeutics (MSTX) Announces Amendment To Loan And Security Agreement With Hercules Technology Growth Capital 9/30/2015
NeuroMod Announces €5.5 million in Financing to Advance Neuromodulation Based Medical Device to Treat Chronic Tinnitus 9/29/2015
Bay Area's Corvus Pharma Bags $75 Million Series B 9/29/2015
ABIVAX - 2015 Half-Year Results €57.7 Million Raised On Euronext And Significant Clinical Progress On Chronic Hepatitis B And HIV/AIDS 9/29/2015
Medtronic (MDT) Forks Over $500 Million Restructuring Charge 9/29/2015
Precision NanoSystems Raises $13.4M In Series A Financing 9/29/2015
Apitope Raises €12 Million In Series B Funding To Progress Treatments For Autoimmune Diseases 9/29/2015
Oncobiologics Secures Financing From Sabby Management, LLC, To Advance BioSymphony Platform And Monoclonal Antibody Biosimilars Pipeline 9/29/2015
Intra-Cellular Therapies Announces Closing Of $345 Million Public Offering Including Exercise Of Underwriters' Option To Purchase Additional Shares 9/29/2015
Evoke Pharma, Inc. Reaches Study Enrollment Milestone Associated With Credit Facility 9/29/2015
Nexvet Receives FY2015 Cash Refund Of $3.2 Million 9/29/2015
AEterna Zentaris (AEZS) Announces TSX Approval Of Series B Warrant Amendment 9/28/2015
GenomeDx Biosciences Secures Financing From CRG 9/28/2015
Mount Sinai Medical Center Release: NIH Awards Funds For Planning A Second Chelation Study 9/28/2015
Cellectar Biosciences  (NVLT) Announces Pricing Of $3.3 Million Financing 9/28/2015
Auris Surgical Robotics Nabs $150 Million in Funding, Remains Mum on Use of Financing 9/25/2015
Genovis is Reorganizing and Closing Its Subsidiary GeccoDots 9/25/2015
VaxAlta: Alberta Livestock Vaccine Research Gets a $660,000 Booster 9/25/2015
Former BioVex CEO Who Sold to Amgen (AMGN) for $1 Billion Raises $30 Million for Replimune 9/25/2015
Company Run by St. Jude Medical (STJ) Founder Officially Shuts Down 9/24/2015
GE Healthcare Commits $300 Million to New Emerging Markets Unit 9/24/2015
Caladrius Biosciences Receives Award From The National Cancer Institute 9/24/2015
Aperion Biologics Announces The Filing Of An Offering Statement To Raise $20 Million In A Public Offering Under Regulation A -- WR Hambrecht + Co To Act As Sole Underwriter 9/24/2015
lifeIMAGE Secures Investment From Blue Cross Blue Shield Of Massachusetts’ Zaffre Investments 9/24/2015
Amgen (AMGN)'s Two-Pronged Strategy: Cancer and Cholesterol 9/23/2015
Intra-Cellular Therapies Prices $300 Million Public Offering Of Common Stock 9/23/2015
Corvia Medical Nabs $34 Million for Heart Failure Implant 9/23/2015
New Translational Science Company DEXSTR Announces Seed Funding And Presents Innovative Data Management Tool Inquiro At Pharmaceutical IT Congress 9/23/2015
Xenios Receives Cash Infusion From Existing Investors To Expand Commercial Operations In U.S. And Europe 9/23/2015
Orexigen (OREX) Receives Payments Totaling $22 Million From U.S. And Korean Partners 9/23/2015
Aesica To Benefit From Investment In New £137 Million Northumberland Green Energy Plant 9/23/2015
Former Genzyme CEO Henri Termeer Leads $10 Million Series B for Autoimmune Company Artax Biopharma 9/22/2015
Veran Medical Technologies Reels In $30.6 Million for Lung Cancer Diagnosis Technology 9/22/2015
AEterna Zentaris (AEZS) Announces Amendment To Series B Warrants 9/22/2015
Berkeley Lights Emerges from Stealth Mode with $90 Million in the Bank 9/21/2015
Akari, Deciphera Both Nab $75 Million in Financing 9/21/2015
Can-Fite BioPharma (CFBI) Announces $9 Million Registered Direct Offering 9/21/2015
CASI Pharmaceuticals  (CASI) To Raise $25.1 Million In Private Placement Of Common Stock And Warrants 9/21/2015
Rhinomed Raises $2.5m In Private Placement 9/18/2015
Bristol-Myers Squibb (BMY) Announces Dividend 9/18/2015
Bay Area Tascent Emerges With $18.5 Million Series A Round 9/18/2015
Medivation (MDVN) Effects A Stock Dividend On Its Common Stock 9/18/2015
Serum Institute of India, Ltd. in Stake Sale Talks at $12 Billion Valuation 9/18/2015
TWi Pharmaceuticals, Inc. Issues GDR And Raised NT$ 2.83 Billion 9/17/2015
Harvard Medical School Receives $20 Million From Warren Alpert Foundation 9/17/2015
Inno-Gene Raises Stake in VitainSillica to 52.8 Pct 9/17/2015
Crystal Pharmatech, A China-U.S. CRO, Raises $10 Million From Renren 9/17/2015
Osiris Therapeutics, Inc. (OSIR) Announces Special Dividend 9/17/2015
Agilent (A) Announces Cash Dividend Of 10 Cents Per Share 9/17/2015
Harpoon Medical Raises $1.4 Million 9/16/2015
La Jolla Pharma (LJPC) Closes Offering Of Common Stock 9/16/2015
Cowen and Company Analysts Predict Healthcare Is Google (GOOG)’s Next Big Target 9/15/2015
Desktop Genetics Ltd Raises £1.37 Million GBP ($2.15M USD) Funding 9/15/2015
Aegerion (AEGR) Grants Stock Options Under Inducement Program 9/15/2015
PDL BioPharma (PDLI) Completes Regular Quarterly Dividend Payment 9/15/2015
PAREXEL International (PRXL) Announces Stock Repurchase Program 9/15/2015
Stereotaxis, Inc. (STXS) Announces Ex-Warrants Date Of September 15, 2015 For Warrants Offering 9/15/2015
TetraPhase (TTPH) Executive Profits Off Stock Sale Hours Before Company Announces Clinical Trial Failure, Report Says 9/15/2015
Gilead (GILD) Borrows $10 Billion, Spurring Acquisition Speculation 9/11/2015
ULURU Inc. To Raise $1,550,000 In Private Placement 9/11/2015
Connecticut Bioscience Innovation Fund Invests $10 Million In Program In Innovative Therapeutics For Connecticut’s Health (PITCH) 9/10/2015
Novadip Nabs EUR 28 Million to Advance Breakthrough Cell Therapy Pipeline 9/10/2015
Delphinus Scores Over $39 Million in Capital 9/10/2015
Forbion Announces The Closing Of FCF II Co-Invest Fund I At EUR 75 Million 9/10/2015
Orexigen (OREX) Raises $60 Million In Sale Of Common Stock To Baupost 9/10/2015
With Ex-InterMune (ITMN) Exec at Its Helm, AveXis Scores $65 Million 9/9/2015
Johnson & Johnson (JNJ) Sets Up Biotech Incubator for 50 Startups in Toronto 9/9/2015
Vestagen Technical Textiles, Inc. Release: Protective Apparel Innovator Vestagen Completes $3.3 Million Bridge Financing 9/9/2015
Groundwork BioAg Closes Series B Investment Round 9/9/2015
Pancreatic Cancer Action Network Release: Nearly $10 Million To Be Invested To Support Pancreatic Cancer Research 9/9/2015
Agenus (AGEN) Trades Away Future Royalties on Sales of GlaxoSmithKline (GSK) Drug for $115 Million 9/9/2015
Agenus (AGEN) Completes $115 Million Non-Dilutive Royalty Transaction With Oberland Capital 9/9/2015
Aclaris Therapeutics Nabs $40 Million, Strikes Skin Disorders Pact with Rigel (RIGL) 9/9/2015
Massachusetts' Selecta Banks Another $38 Million 9/8/2015
GlaxoSmithKline (GSK) Takes a Bigger Stake in Socal Startup Set Point With $15 Million Funding Round 9/8/2015
Audion Therapeutics Raises Funds To Advance The Development Of Hearing Loss Treatment 9/8/2015
Repositive Starts Series A Fundraising 9/8/2015
Sanifit Raises €36.6M ($41M) In Series C Financing Round 9/8/2015
Reviral Announces Us$21 Million Fundraising To Advance Clinical Development Of A Novel Anti-Viral Drug 9/8/2015
Spanish Biotech Sanifit Nabs $41 Million to Advance Lead Candidate 9/8/2015
BioGaia To Invest Further In Infant Bacterial Therapeutics AB 9/8/2015
Proteostasis Therapeutics, Inc. Raises $37 Million In Crossover Financing 9/8/2015
Cognition Therapeutics Inc. Completes Oversubscribed $12 Million Series B Financing 9/8/2015
Amedica Corporation Enters Into Definitive Agreements To Raise $15.0 Million In Equity Financing 9/8/2015
Akers Biosciences, Inc. To Present At Rodman & Renshaw 17th Annual Global Investment Conference 9/8/2015
Guided Therapeutics Announces $550,000 Increase To $4 Million Private Placement And Accelerated Interim Closing 9/3/2015
Grand Angels Grows With Strategic Biotech And Life Science Investments 9/3/2015
X4 Pharma Bags $37.5 Million in Funding, Backed by Former Genzyme Execs 9/3/2015
Baxter International (BAX) Gets Ready to Unload $1.45 Billion Baxalta Stake 9/3/2015
ADC Therapeutics Scores $80 Million to Progress Antibody Pipeline 9/2/2015
Ascletis, Inc. Scores $35 Million Financing 9/2/2015
Exosome Diagnostics Reels In $17.6 Million 9/2/2015
Aytu BioScience Completes $5.175 Million Private Placement 9/2/2015
Ivenix Secures $42 Million for Drug Infusion Technology 9/2/2015
OncoVista Innovative Therapies, Inc. Updates Investors On Financings And Strategic Options 9/2/2015
Getinge Lays Out New Restructuring Plan 9/2/2015
Insulin Infusion Device Maker CeQur Bags $100 Million 9/1/2015
Cesca Therapeutics Secures $15 Million Financing From Institutional Life Sciences Fund 9/1/2015
Miromatrix Medical Inc. Nabs $23 Million for Decellularizing Tech 9/1/2015
Opexa Therapeutics (OPXA) Secures Private Funding For Its NMO Orphan Development Program, Including Planned Phase I/II Clinical Study 9/1/2015
Cure Duchenne Ventures LLC Provides $1 Million To Myotherix To Advance Promising Research To Treat Duchenne Muscular Dystrophy 9/1/2015
BIOREM Technologies Inc. Orders Totalling $5.7 Million 9/1/2015
Intellia Closes on $70 Million Series B Round, Plans to Hire 20 9/1/2015
LabStyle Innovations Closes $2.5 Million Funding To Support Global Rollout Of Dario Diabetes Management Solution 8/31/2015
AxoGen (AXGN) Locks In $17 Million Investment from Essex Woodlands 8/28/2015
Boston Pharma Companies Support Democratic Candidates and Groups, Report Says 8/27/2015
PE Firm Dumps up to $28.4 Million in Itamar Medical Ltd. 8/27/2015
Soligenix (SNGX) Receives Additional National Institute of Allergy And Infectious Diseases (NIAID) Funding To Advance Development of OrbeShield In GI ARS 8/27/2015
Merus Banks 72.8 Million Euro Series C 8/26/2015
ReShape Medical Reels In $38 Million 8/26/2015
MediBeacon Enters into $22.4 Million Financing Deal 8/26/2015
Advaxis, Inc. Announces Licensing Agreement With Knight Therapeutics and Raises $25 Million Through Direct Investments From Knight and Sectoral Asset Management 8/26/2015
Providence Medical Tech Announces New Financing of $12 Million 8/26/2015
Panther Biotechnology Announces $1.215 Million Financing With Chicago Venture Partners 8/26/2015
FluGen Closes $12 Million Series A Financing 8/25/2015
DynoSense Closes $9.4 Million Series A Funding Round 8/25/2015
Massachusetts' Syndax Banks $80 Million Series C 8/24/2015
North Carolina's Hatteras Venture Scores $90 Million Life Sciences, Health IT Fund 8/24/2015
Bay Area's TriVascular Tech (TRIV) Nabs $10 Million, Launches EVAR Study in Women 8/24/2015
TxCell Consortium Granted EUR 1.28 Million For TRUST Project On Process And Clinical Development Of Col-Treg For Autoimmune Uveitis Treatment 8/24/2015
PE Firm Aisling Plots $400 Million Life Sciences Fund 8/21/2015
Kindara to Hire, Nabs $5.3 Million to Support Fertility Monitoring Tools 8/21/2015
Marrone Bio Innovations, Inc Announces Completion Of $40 Million Loan Financing; Update On Management And NASDAQ Matters 8/21/2015
Telesta Therapeutics Bags $28.6 Million 8/20/2015
LDR (LDRH) Secures $86 Million After Stock Sale 8/20/2015
ViewRay Locks In $29.4 Million 8/20/2015
AgBiome Secures $34.5 Million Series B Financing 8/20/2015
Jaguar Animal Health Secures Debt Financing 8/20/2015
GeneNews (GEN.TO) Raises $1.26 Million In Non-Brokered Private Placement 8/20/2015
Illumina (ILMN) Forms New Bay Area Firm Helix With $100 Million 8/20/2015
Bay Area Startup Orbus Nabs $32.5 Million Series A 8/20/2015
EBS Technologies Raises Additional 1.1 Million Euros In New Round Of Financing 8/19/2015
Boston Startup Wave Life Sciences Nabs $66 Million 8/19/2015
Thrive Biosciences, Inc. Raises $4.0 Million Seed Round To Provide Previously Unavailable Automation And Analytics To Cell Culture And Stem Cell Culture 8/19/2015
Soligenix (SNGX) Receives Additional National Institute of Allergy And Infectious Diseases (NIAID) Funding To Advance Development Of Heat Stable Ricin Vaccine 8/19/2015
Accounting Blunders Cost Hanger (HGR) $28 Million 8/19/2015
Ocata Therapeutics Secures $10 Million In Debt Financing 8/19/2015
Celsus Therapeutics (CLTX) and Volution Immuno Pharmaceuticals Announce $75 Million Private Placement 8/18/2015
Quanta Receives £1.85 Million I4i Award To Develop An Advanced Haemodialysis System For Nocturnal Use 8/18/2015
San Diego's Genalyte Locks In $44 Million Financing 8/18/2015
After Withdrawing IPO, DermTech Seeking $20 Million 8/18/2015
VBI Vaccines Announces Closing Of $6.29 Million Private Placement 8/18/2015
Kuros Biosurgery AG Announces The Successful Closing Of A CHF 15 Million Financing Round 8/18/2015
Anpac Bio-Medical Successfully Achieves Series A Funding From Shanghai Zhangjiang Science & Technology Investment Corporation 8/18/2015
DelMar Pharmaceuticals Receives Additional Non-Dilutive Funding From NRC-IRAP To Support Expanded Research Program With Lead Product Candidate VAL-083 8/17/2015
Evolve BioSystems Inc. Completes $9 Million Series A Investment 8/17/2015
Synpromics Receives £2.1 Million From Calculus Capital 8/14/2015
IP Group plc – Portfolio Company First Light Fusion Completes £22.7 Million Funding Round 8/14/2015
Rhythm Metabolic Banks $40 Million Series A 8/13/2015
Checkmate Comes Out of Stealth Mode With $20 Million and Ex-Sarepta (SRPT) Exec as Its Leader 8/13/2015
Former Teva (TEVA) CEO Banks $75 Million for Neurology Startup Ovid 8/13/2015
Senseonics Reels In $10 Million for Implanted Glucose Sensor 8/13/2015
Rosellini Scientific, LLC Receives $790,000 Fast Track SBIR, Names Ron Conquest Chief Operating Officer 8/12/2015
One-time IPO Candidate TherOx Nabs $23.19 Million 8/11/2015
Portage Biotech's Biohaven Raises $ 4.1 Million In First Tranche Of Private Placement. Portage Invests $ 2.5 Million 8/11/2015
Rapid Micro Biosystems Expands Series C Round With Investment From EDBI 8/11/2015
Ascentage Pharma Lands $15.5 Million In Round A Financing 8/11/2015
Bill & Melinda Gates Foundation, Crossovers Dump $120 Million Into Editas Medicine to Advance Genome Editing 8/10/2015
Portage Biotech Invests In Sentien Biotechnologies Inc. 8/10/2015
ADM Tronics Unlimited (ADMT) Receives Strategic Investment From Advanced Plasma Therapies 8/10/2015